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Research
The rapid growth in the commercial use of   
silver nano  particles (AgNPs) is increasing silver 
exposure in the general population (Wijnhoven 
et al. 2009). AgNPs are incorporated into prod­
ucts primarily as an anti  microbial, reflecting 
their release of mono  valent silver ion (Ag+) 
(Wijnhoven et al. 2009). However, the same 
mechanisms that make Ag+ an anti  microbial 
also render it a potential develop  mental neuro­
toxicant. Silver crosses the placenta and con­
centrates in the human fetus, achieving higher 
concentrations than in the mother (Lyon et al. 
2002). Animal studies show accumulation 
in the developing brain, develop  mental dys­
morphology, and behavioral changes in exposed 
adults (Rungby 1990). Importantly, AgNP 
exposure via either inhalation or oral routes also 
leads to Ag accumulation in the adult rodent 
brain (Wijnhoven et al. 2009), altering the 
expression of genes involved in neuronal func­
tion (Rahman et al. 2009). We recently showed 
that in PC12 cells, a well­established model of 
neuronal develop  ment, Ag+ disrupts key mecha­
nisms involved in cell replication and neuro­
differentiation (Powers et al. 2010a); we then 
demon  strated that nervous system develop  ment 
is disrupted in developing zebrafish exposed 
to Ag+ (Powers et al. 2010b). Unlike primary 
neuronal cultures, PC12 cells provide a homo­
geneous population that continues to divide 
until differentiation is triggered by addition of 
nerve growth factor. Accordingly, this model 
allows direct study of effects on DNA synthesis 
associated with cell replication, an important 
target of neuro  toxicants; the cells then differ­
entiate into distinct acetylcholine (ACh) and 
dopamine (DA) phenotypes.
It is thus critical to assess the extent to 
which AgNPs can elicit the same or different 
types of neuro  develop  mental outcomes as 
Ag+. In the same PC12 model, high concen­
trations of AgNPs disrupt the cell membrane 
and impair mitochondrial function (Hussain 
et al. 2006) while altering gene expression 
related to oxidative stress (Wang et al. 2009); 
however, these studies were not carried out in 
the context of neuro  differentiation (Powers 
et al. 2010a). In the present study, we carried 
out extensive experiments on replicating and 
differentiating PC12 cells, comparing and 
contrasting the effects of AgNPs with those 
of Ag+. We then evaluated the roles of par­
ticle size, coating, and composition, issues of 
potential importance in assessing the toxicity 
of different AgNP formulations (Teeguarden 
et al. 2007). We chose AgNPs covering a 
range of particle sizes and coatings, charac­
terizing both their physi  cal properties in sus­
pension as well as their biological effects. We 
focused first on compari  sons between Ag+ 
and citrate­coated AgNPs (AgNP­C). This 
was followed by evaluations of the effects of 
different coatings and sizes, using polyvinyl­
pyrrolidine­coated AgNPs (AgNP­PVPs), and 
by assessments using uncoated silica nano­
particles (SiNPs) to determine whether effects 
could be elicited simply by particles of the 
same size, regardless of the main composi­
tion constituent. Nanoparticle coatings are 
intended to promote stability and dispens­
ability through surface polarity that prevents 
agglomeration, and the two types of coatings 
chosen here are common to many types of 
nano  particles. Commercially available nano­
particle formu  la  tions have different ranges of 
sizes, which can have profound influence over 
their biologic activities (Teeguarden et al. 
2007). Our evalua  tions were modeled after 
our earlier work on the develop  mental neuro­
toxicity of Ag+ (Powers et al. 2010a), focusing 
on anti  mitotic effects, inhibition of protein 
synthesis, oxidative stress, impaired viability, 
and neuro  differentiation into ACh and DA 
pheno  types. Here, we show that the effects 
of AgNPs do not reflect solely their ability to 
release soluble Ag+, but instead are influenced 
by specific nano  particle characteristics that 
dictate different biologic outcomes.
Materials and Methods
Nanoparticle preparation and charac  teriza-
tion. AgNP­C was synthesized at Duke 
University using established methods (Lee 
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Ba c k g r o u n d: Silver exposures are rising because of the increased use of silver nanoparticles 
(AgNPs) in consumer products. The mono  valent silver ion (Ag+) impairs neurodevelopment in 
PC12 cells and zebrafish.
oBjectives a n d M e t h o d s : We compared the effects of AgNPs with Ag+ in PC12 cells for neuro  -
developmental end points including cell replication, oxidative stress, cell viability, and differen-
tiation. First, we compared citrate-coated AgNPs (AgNP-Cs) with Ag+, and then we assessed the 
roles of particle size, coating, and composition by comparing AgNP-C with two different sizes of 
polyvinylpyrrolidone-coated AgNPs (AgNP-PVPs) or silica nanoparticles.
re s u l t s: In undifferentiated cells, AgNP-C impaired DNA synthesis, but to a lesser extent than an 
equivalent nominal concentration of Ag+, whereas AgNP-C and Ag+ were equally effective against 
protein synthesis; there was little or no oxidative stress or loss of viability due to AgNP-C. In con-
trast, in differentiating cells, AgNP-C evoked robust oxidative stress and impaired differentiation 
into the acetyl  choline phenotype. Although the effects of AgNP-PVP showed similarities to those 
of AgNP-C, we also found significant differences in potencies and differentiation outcomes that 
depended both on particle size and coating. None of the effects reflected simple physical attributes 
of nano  particles, separate from composition or coating, as equivalent concentrations of silica nano-
particles had no detectable effects.
co n c l u s i o n s: AgNP exposure impairs neuro  development in PC12 cells. Further, AgNP effects are 
distinct from those of Ag+ alone and depend on size and coating, indicating that AgNP effects are 
not due simply to the release of Ag+ into the surrounding environment.
Key words: acetylcholine, developmental neuro  toxicity, dopamine, in vitro, metal neuro  toxicity, 
nano  particles, PC12 cells, silver. Environ Health Perspect 119:37–44 (2011).  doi:10.1289/
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and Meisel 1982). We purchased AgNP­PVP 
and uncoated SiNPs in powder form from 
Nanostructured & Amorphous Materials Inc. 
(Houston, TX). Stock suspensions of nano­
particle powders were prepared in ultra  pure 
water, sonicated continuously at 89–95 W 
power, with amplitude set at 100%, for 20 min 
in an ice bath using a Misonix Sonicator 4000 
(QSonica	LLC,	Newton,	CT) equipped with 
a 1/2 in. diameter flat titanium tip.
Both types of AgNPs were prepared in 
stock solutions equivalent to a nominal con­
centration of 1 mM Ag. For AgNP­C this 
concentration was achieved by using 1 mM 
AgNO3 to synthesize the particles. For 
AgNP­PVP, we weighed out the appropriate 
volume of powder corresponding to 1 mM 
Ag, based on the percent composition from 
the manufacturer’s specifications. SiNP stock 
suspensions were made up to have a particle 
concentration equivalent to that used for the 
10­nm AgNPs, based on AgNP and SiNP par­
ticle volumes and densities. Table 1 describes 
the concentration of each stock suspension in 
terms of the nominal Ag concentration (con­
centration corresponding to the Ag concentra­
tion that would be achieved if all the Ag were 
freely dissolved), the concentration of particles, 
and the mass of particles per milliliter.
We evaluated dry particle size and mor­
phology using transmission electron micros­
copy at 160 kV (Tecnai G2 Twin; FEI 
Company, Hillsboro, OR) by adding 10 µL 
of the sample to a lacey carbon/copper grid 
(300 mesh; Electron Microscopy Sciences, 
Hatfield, PA) and allowing samples to air dry. 
Images were analyzed using Image­Pro, ver­
sion 4.5 (Media Cybernetics, Inc., Bethesda, 
MD). Particle size in suspension was assessed 
using dynamic light scattering using a 
CGS 3 goniometer (ALV­GmbH, Langen, 
Germany) equipped with a helium­neon laser 
(633.4 nm). Suspensions were analyzed at 
25°C in 5­mM diameter cells with the photo­
multiplier set to a scattering angle of 90°. The 
nominal Ag concentration in stock suspen­
sions was measured using inductively coupled 
plasma­optical emission spectroscopy (Prism 
ICP High Dispersion; Teledyne Leeman Labs, 
Hudson, NH) and graphite flame atomic 
absorption (PerkinElmer, Waltham, MA). For 
PVP­coated particles, we meas  ured the poly­
mer concentration by baking the particles at 
540°C for 18 hr in a muffle furnace; the pure 
silver weight was calculated from the weight of 
residual silver oxide formed at the end of bak­
ing. The concentration of any free PVP was 
assessed using a total organic carbon analyzer 
(TOC­5050A; Shimadzu, Columbia, MD).
Cell cultures and assays. All materials 
and cell culture and assay techniques used in 
this study have been reported previously and 
were specifically used in our earlier study of 
Ag+ effects in the PC12 model (Powers et al. 
2010a); therefore, we will provide only a 
brief procedural outline here. For studies in 
the undifferentiated state, the medium was 
changed 24 hr after seeding to include test 
reagents. For studies in differentiating cells, 
24 hr after seeding, the medium was changed 
to include nerve growth factor, and each cul­
ture was examined under a microscope to ver­
ify the subsequent outgrowth of neurites. Test 
agents were added concurrently with the start 
of nerve growth factor treatment, and cultures 
were maintained for up to 6 days, with the 
indicated agents included with every medium 
change (48­hr intervals).
Cells were harvested and washed, and 
the DNA, total protein, and membrane 
protein fractions were isolated and analyzed 
as described previously (Song et al. 1998). 
Because neuronal cells contain only a single 
nucleus (Winick and Noble 1965), measur­
ing the DNA content in each dish provides 
a measure of cell number. The protein/DNA 
ratio was calculated as an index of cell size, 
and the membrane/total protein ratio was used 
to assess the rise in membrane complexity that 
accompanies neurite outgrowth during neuro­
differentiation. We measured DNA synthe­
sis by assessing [3H]thymidine incorporation 
into the DNA fraction (Song et al. 1998); 
similarly, protein synthesis was assessed by 
incorporation of [3H]leucine into the pro­
tein fraction. Oxidative stress was evaluated 
through measuring the formation of lipid per­
oxides by reaction of the resultant malondial­
dehyde	(MDA)	with	thio	 barbituric	acid	(Qiao	
et al. 2005). Cell viability was meas  ured by 
blinded cell counts after trypan blue staining. 
Differentiation into ACh and DA phenotypes 
was determined enzymatically by measuring 
choline acetyltransferase (ChAT) and tyrosine 
hydroxylase (TH) activities, respectively (Lau 
et al. 1988; Waymire et al. 1971). We also 
included samples containing Ag+ to serve as a 
positive test compound for compari  son with 
the effects of the AgNPs; these represent new 
values, not a restatement of our published 
results with Ag+ (Powers et al. 2010a). The 
time points for differentiating cells were cho­
sen based on our prior work with Ag+, show­
ing progressive loss of DNA content over a 
span of 4–6 days in culture and changes in 
neuro  transmitter pheno  type at the 6­day point 
(Powers et al. 2010a). Loss of viability and 
oxidative stress produce eventual cell loss, so 
those measurements were made at 4 days.
We incorporated a number of different 
controls in our cell culture assays to account 
for differences specific to each type of nano­
particle or experi  mental condition, and these 
are described in the figure legends. In our pre­
vious study (Powers et al. 2010a) we found 
no effect of nitrate ion on any of these param­
eters and thus did not include this additional 
control in the present study. Similarly, we 
did not include citrate controls because the 
culture medium already contains citrate in 
substantial concentrations from the added 
fetal bovine and horse serum.
Data analysis. All studies were performed 
on 8–16 separate cultures for each measure 
and treatment, using 2–4 separate batches 
of cells. Results are presented as mean ± SE. 
Treatment effects were established by analysis 
of variance (ANOVA), followed by Fisher’s 
protected least significant difference test for 
post hoc compari  sons of individual treat­
ments; data were log­transformed whenever 
the variance was hetero  geneous. In the ini­
tial test, we evaluated two ANOVA factors 
(treatment and cell batch) and found that 
the results did not vary among the different 
batches of cells, so results across the differ­
ent batches were normalized and combined 
for presentation. Significance was assumed at 
p < 0.05 (two­tailed).
Results
Nanoparticle characteristics. The vast majority 
of nano  particles were spherical. AgNP­C was 
poly  disperse (Figure 1A), with an average dry 
particle size of 6 nm; 85% were < 10 nm, and 
the remaining 15% were < 63 nm (Figure 1B). 
In suspension, particles swelled or aggregated, 
producing a higher hydro  dynamic radius com­
pared with dry particles. The size remained 
stable over time (Figure 1C), indicating either 
that aggregated particles fell out of suspen­
sion or that they represented only a small 
proportion. We examined the particle con­
centration under culture conditions over the 
48­hr time period between medium changes, 
using spectro  photometry at 540 and 570 nm 
to assess absorption by the particles suspended 
in the cell culture medium, focusing on the 
highest concentration (100 µM nominal Ag), 
which would be most likely to aggregate. 
The suspended nano  particle concentration 
remained unchanged over 48 hr: 0.030 optical 
density units above culture medium alone at 
24 hr, and 0.034 at 48 hr (triplicate samples). 
Thus, particles in suspension tended to aggre­
gate somewhat over time but maintained their 
average size and concentration, indicating that 
aggregation was not a significant problem.
Table 1. Nanoparticle stock suspension concentrations.
Measure
AgNP-C 
10 nm
AgNP-PVP 
10 nm
AgNP-PVP 
50 nm
SiNP 
25 nm
Nominal Ag (mM) 1 1 1 0
Particles per milliliter 2 × 1013 2 × 1013 3 × 1011 2 × 1013
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We carried out similar evaluations of 
AgNP­PVP. Dry particles designated to have 
a 10­nm diameter actually averaged 21 nm, 
with 88% at < 25 nm and the remainder at 
< 200 nm. The designated 50­nm AgNP­PVP 
actually averaged 75 nm, with 57% at < 81 nm 
and the remainder at < 200 nm. Our analy­
sis of dry SiNP showed good agreement with 
the manufacturer’s stated description of par­
ticle size and shape. Similar to AgNP­C, both 
PVP­coated particles and SiNP showed a small 
degree of aggregation once in suspension, but 
the effects were of insufficient magnitude to 
cause major changes in the suspended nano­
particle concentration (Figure 1C). We also 
used a total organic carbon analyzer to measure 
the PVP concentration in the AgNP­PVPs. 
We found PVP concentrations of 15% and 
13% of total AgNP weight for 10­ and 50­nm 
particles, respectively, markedly higher than 
the stated concentrations of 0.2–0.3%. In pre­
paring our stock concentrations, we used 10% 
PVP (i.e., between our values and the manufac­
turer’s). The measured values for Ag in the dry 
Ag­PVPs were within 15% of those expected.
Throughout the results, we present the 
nano  particle concentration in two differ­
ent metrics: the nominal Ag concentration 
(defined as the equivalent of all the Ag being 
in free solution) and the number of particles 
per unit volume. The equivalent amount for 
each nano  particle (mass per unit volume) 
appears in Table 1.
AgNP-C in undifferentiated cells. We first 
compared the anti  mitotic effects of AgNP­C 
with those of Ag+. With a 24­hr exposure, we 
found a concentration­dependent decrease 
in DNA synthesis starting at AgNP­C cor­
responding to a nominal Ag concentration of 
1 µM, but in all cases the effects were smaller 
than those seen with 10 µM Ag+ (Figure 2A). 
To determine if binding of AgNPs to serum 
proteins was responsible for the smaller effect 
compared with Ag+, we meas  ured DNA syn­
thesis in cells exposed to AgNP­C or Ag+ with 
and without serum for 1 hr, a span in which 
cells maintain their viability in the absence of 
serum (Figure 2B). Removing serum from the 
medium greatly enhanced the effect of Ag+, 
reflecting a high degree of binding to serum 
proteins. However, there was no correspond­
ing enhancement for AgNP­C.
To determine if the reduction in DNA 
synthesis evoked by AgNP­C reflected a spe­
cific action on mitotic activity, we examined 
corresponding effects of a 24­hr exposure 
on protein synthesis (Figure 2C). For Ag+, 
the reduction in protein synthesis was much 
smaller than that seen for DNA synthesis. In 
contrast, for AgNP­C, protein synthesis was 
inhibited to about the same extent as had been 
observed for its effects on DNA synthesis up 
to a nominal Ag concentration of 10 µM. 
However, unlike the situation for DNA syn­
thesis, the effect on protein synthesis was lost 
at higher concentrations.
In undifferentiated cells, Ag+ produced 
robust oxidative stress after a 24­hr exposure, 
whereas AgNP­C was ineffective (Figure 2D). 
Likewise, Ag+ was much more cyto  toxic, 
evoking a large reduction in cell viability 
compared with the much smaller effect of 
AgNP­C (Figure 2E); similar to the effect on 
protein synthesis, AgNP­C above a nominal 
Ag concentration of 10 µM became less effec­
tive. Finally, meas  ures of cell number after 
a 24­hr exposure (DNA content) confirmed 
that Ag+ evoked a much greater cell loss than 
did AgNP­C (Figure 2F) and, again, we saw a 
non  monotonic effect of the nano  particles.
AgNP-C in differentiating cells. Unlike the 
situation in undifferentiated cells, AgNP­C 
exceeding a nominal Ag concentration of 
3 µM produced significant oxidative stress 
after 4 days of exposure, in the same range as 
Ag+ (Figure 3A). Increased oxidative stress was 
not secondary to general cytotoxicity, as the 
AgNP­C effect on viability remained much 
smaller than that of Ag+ (Figure 3B); further­
more, although the dose–effect relationship 
was mono  tonic for oxidative stress, it was non­
monotonic for loss of viability. At the same 
4­day exposure, cell number decreased much 
more at 10 µM Ag+ than at comparable or 
higher concentrations of AgNP­C (Figure 3C); 
for AgNP­C, we observed small but signifi­
cant decrements at nominal Ag concentra­
tions of 10 and 100 µM, albeit not at 30 µM. 
Furthermore, by 6 days of exposure, cell num­
ber recovered so that there was no detectable 
loss at any concentration; in fact, there was an 
increase in cell number at the lowest AgNP­C 
concentration (Figure 3C). In contrast, expo­
sure to Ag+ simply produced a progressive cell 
loss beyond that seen at the 4­day point.
We also assessed indices of cell growth and 
neuro  differentiation. None of the AgNP­C 
concentrations produced significant changes 
in the total protein/DNA ratio (data not 
shown), an index of cell size. Nevertheless, 
AgNP­C had a progressive effect on the 
membrane/total protein ratio, an index of 
neurite outgrowth, achieving statistical sig­
nificance at a nominal Ag concentration of 
30 µM (Figure 3D); 10 µM Ag+ impaired 
neurite formation to about the same extent. 
A 6­day exposure to AgNP­C at a nominal 
Ag concentration of 30 µM clearly decreased 
emergence of the ACh pheno  type [ChAT 
activity (mean ± SE): control, 109 ± 6 pmol/
hr/µg DNA; AgNP­C, 69 ± 1 pmol/hr/µg 
DNA; p < 0.0001; n = 8) without significantly 
affecting the DA phenotype (TH activity: 
control, 118 ± 6 pmol/hr/µg DNA; AgNP­C, 
110 ± 7 pmol/hr/µg DNA; not significant, 
n = 8). Accordingly, the TH/ChAT ratio rose 
(control, 1.09 ± 0.04; AgNP­C, 1.66 ± 0.10; 
p < 0.002), indicating a phenotype shift.
Ascorbate prevents oxidative stress and cell 
loss caused by exposure to Ag+ (Powers et al. 
2010a). Accordingly, we performed comple­
mentary experiments with AgNP­C at a nomi­
nal Ag concentration of 10 µM. We found the 
same increase in MDA in the presence of ascor­
bate (mean ± SE:10 µM, 17 ± 2% increase; 
Figure 1. Nanoparticle characteristics. (A) Transmission electron microscopy of AgNP-C, showing both unaggregated and aggregated nanoparticles. 
(B) Distribution of AgNP-C dry particle sizes. (C) Dynamic light scattering measurements of particle diameter in stock suspensions (mean of 20 measurements), 
showing slight aggregation for all particles.
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p < 0.0001; n = 20) and loss of DNA (20 ± 2% 
decrease; p < 0.0001; n = 20) as without ascor­
bate (Figure 3A,C). 
Effects of nano  particle coating, size, and 
composition. In undifferentiated cells, a 24­hr 
exposure to AgNP­PVP with manufacturer­
designated diameters of either 10 or 50 nm 
at a nominal Ag concentration of 30 µM 
evoked signifi  cant decreases in DNA synthe­
sis (Figure 4A). Notably, the decrement for 
the 50­nm AgNP­PVP exceeded that caused 
by the smaller AgNP­PVP or by AgNP­C. 
SiNP had a smaller (non  significant) effect 
than any of the AgNPs. Similar measures of 
protein synthesis showed no discernible effect 
of either 10 or 50 nm AgNP­PVP at nominal 
Ag concentrations of 10 or 30 µM, whereas 
10 µM AgNP­C clearly inhibited synthesis 
(Figure 4B). SiNPs had no effect. With the 
same 24­hr exposure to a nominal 10 µM 
Ag concentration, AgNPs reduced cell num­
ber, with the greatest effect from AgNP­PVP 
50 nm, followed by AgNP­C, and no effect 
for AgNP­PVP 10 nm (Figure 4C); however, 
at a 30 µM nominal Ag, the effect of 50 nm 
AgNP­PVP or AgNP­C was reduced or lost. 
Again, SiNPs had no effect.
We next compared the effects of particle 
size, coating, and composition in differentiat­
ing cells. With a 4­day exposure, we found 
oxidative stress for all three types of AgNPs, 
whereas SiNP was ineffective (Figure 5A). 
Either size of AgNP­PVP decreased cell num­
ber at 4 days (Figure 5B); by 6 days, the effect 
regressed to normal for the smaller AgNP­PVP 
particle but not for the larger particle. AgNP­C 
at the same nominal concentration had no 
measurable effect on cell number at either 
time point (Figure 5B, replicating the results 
seen in Figure 3C). Both sizes of AgNP­PVP 
increased the index of cell size at 6 days: 
9 ± 3% (mean ± SE) increase in the total 
protein/DNA ratio for 10 nm AgNP­PVP 
(p < 0.01; n = 20), 7 ± 2% increase for 50 nm 
AgNP­PVP (p < 0.04; n = 20; control ratio 
Figure 2. Effects of AgNP-C on undifferentiated PC12 cells shown by (A) DNA synthesis (24-hr exposure), (B) DNA synthesis in the presence or absence of serum 
(1 hr exposure), (C) protein synthesis (24-hr exposure), (D) oxidative stress (24-hr exposure), (E) trypan blue exclusion (24-hr exposure), and (F) DNA content (24-hr 
exposure). Data represent mean ± SE of the number of determinations shown in parentheses. ANOVA for each panel indicated a main treatment effect [p < 0.0001; 
(A) F7,110 = 9.2, (B) F7,88 = 123, (C) F7,87 = 8.7, (D) F5,69 = 32, (E) F5,42 = 44, (F) F7,249 = 6.1]. To achieve 100 µM AgNP-C, the culture medium was diluted 10% with AgNP-C 
stock solution; isotonic NaCl and NaHCO3 were then added to achieve isotonicity and to match the NaHCO3 concentration normally in the medium; accordingly, 
these samples have separate controls with the same additions. HC control, high concentration control.
*Significantly different from the corresponding control (p < 0.05 or better) by Fisher’s protected least significant difference test. 
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27.8 ± 0.4 µg/µg) but had no significant effect 
on the membrane/total protein ratio (data not 
shown). Samples with corresponding concen­
trations of AgNP­C run concurrently with 
the AgNP­PVP showed no significant differ­
ence in total protein/DNA. Finally, 10 nm 
AgNP­PVP enhanced differentiation into the 
DA pheno  type, as indicated by a significant 
increase in TH activity relative to control 
values, but neither 50 nm AgNP­PVP nor 
AgNP­C had a comparable effect (Figure 5C). 
In contrast, all three types of AgNPs sup­
pressed the ACh pheno  type, as shown by 
deficits in ChAT activity, but AgNP­C and 
50 nm AgNP­PVP were more effective than 
the smaller­diameter AgNP­PVP. Although 
the under  lying components differed, all of 
the AgNPs increased the ratio of TH/ChAT 
(Figure 5D), reflecting diversion of cells 
toward the DA phenotype and away from the 
ACh phenotype; the net effect was greatest for 
the larger­diameter AgNP­PVP.
Discussion
Our results provide some of the first evidence 
that AgNPs can act as develop  mental neuro­
toxicants in a model of neuronal cell replica­
tion and differentiation. They further point to 
compound effects that depend not only on the 
release of Ag+ but also on particle size, coating, 
and composition. Indeed, if AgNPs acted 
solely by releasing soluble Ag+, then all of their 
effects would resemble those of lower concen­
trations of the soluble ion, because a large pro­
portion of the Ag+ is not dissolved. In that 
case, we would expect to see a decline in AgNP 
effect with increasing particle size because the 
smaller surface­to­volume ratio of larger par­
ticles would render less of the Ag+ available to 
dissolve. Some of our findings followed this 
predicted pattern, but others clearly did not. 
The effects of AgNP­C on undifferentiated 
cells were in the same direction but decidedly 
smaller than those from the same concentra­
tion of freely dissolved Ag+ for comparisons of 
DNA synthesis, oxidative stress, viability, and 
cell loss. However, this was not true for the 
role of plasma protein binding on DNA syn­
thesis, nor for the effects on protein synthesis; 
for the latter, AgNP­C was as effective as Ag+ 
and showed a non  monotonic effect that was 
not seen in our earlier work with Ag+ (Powers 
et al. 2010a). The same pattern of some simi­
larities, coupled with important dichotomies, 
was apparent in differentiating cells. AgNP­C 
produced oxidative stress, decreased viability, 
cell loss, and impaired neurite formation, in 
each case requiring a higher concentration to 
produce effects equivalent to those seen from 
the freely dissolved Ag+. Likewise, in our earlier 
work with Ag+, we found a biphasic effect on 
DNA content between 4 and 6 days of expo­
sure just as seen here for AgNP­C, but involv­
ing a lower Ag+ concentration. Nevertheless, 
AgNP­C failed to evoke the cell enlargement 
(increased total protein/DNA) seen with Ag+; 
furthermore, ascorbate did not protect cells 
from the oxidative stress and cell loss caused by 
AgNP­C, whereas the same treatment protects 
against Ag+ (Powers et al. 2010a). Finally, the 
experi  ments using the two sizes of AgNP­PVP 
showed a relationship opposite what would 
be expected just from release of Ag+ from the 
particle surface: At the same nominal Ag con­
centration, the larger nano  particle had greater 
effects on DNA synthesis and content and 
caused a higher degree of disruption in oxida­
tive stress and neuro  transmitter phenotype.
Clearly, then, the neuro  toxic actions of 
AgNPs involve significant contributions from 
nano  particle formulation, albeit not from only 
the physical dimensions, because SiNPs were 
generally ineffective in producing the effects 
seen with the AgNPs. Nanoparticles can 
produce their unique effects either through 
altering access to the interior of the cell 
(pharmaco  kinetic effects) or through eliciting 
responses that differ from those of the freely 
dissolved materials (pharmaco  dynamic effect). 
Our results for effects on DNA synthesis with 
Figure 3. Effects of AgNP-C on differentiating PC12 cells shown by (A) oxidative stress (4-day exposure), (B) trypan blue exclusion (4-day exposure), (C) DNA 
content (4 and 6-day exposures), and (D) membrane/total protein ratio (6-day exposure). Data represent mean ± SE of the percent change from control, based 
on the number of determinations shown in parentheses. ANOVA for each panel indicated a main treatment effect [p < 0.01 or better; (A) F6,134 = 47, (B) F5,42 = 65, 
(C) F6,133 = 37 at 4 days and F5,74 = 107 at 6 days, (D) F5,66 = 3.6]. HC control, high concentration control. 
*Significantly different from the corresponding control (p < 0.05 or better) by Fisher’s protected least significant difference test. 
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and without serum effectively eliminate the 
possibility that a reduced effect of AgNPs 
results from binding to serum proteins. In fact, 
we found the opposite, namely, that removal 
of serum greatly enhanced the effect of Ag+ 
but not that of AgNP­C. Similarly, we can 
rule out the possibility that nano  particle aggre­
gation limits the concentration of Ag+ avail­
able for biologic effects for two reasons. First, 
we saw little evidence for significant changes 
in the net nano  particle size or concentration 
over time. Second, aggregation would produce 
a parallel change in all the measured effects, 
whereas we saw a mono  tonic concentration–
response curve for some variables but non­
monotonic effects for others.
Instead, our results provide conclusive evi­
dence for unique biologic effects of AgNPs, 
distinct from the actions of freely dissolved 
Ag+ and unrelated to simple pharmaco  kinetic 
attributes. Four key findings support this 
interpretation: 
• The lack of AgNP­C selectivity toward 
DNA versus protein synthesis in undiffer­
entiated cells (whereas Ag+ is highly selective 
toward the former macro  molecule)
• The inability of ascorbate to protect cells 
from oxidative stress and cell loss caused by 
AgNP­C (whereas the same anti  oxidant is 
protective against Ag+) (Powers et al. 2010a), 
which implies that cell loss from AgNP­C 
reflects a different under  lying mecha  nism and 
that, for the nano  material, oxidative stress is a 
result of cyto  toxicity, not a cause of it 
• The greater inhibition of protein synthesis at 
lower AgNP­C concentrations and a loss of 
effect at higher concentrations, totally distinct 
from the mono  tonic dose–effect relation  ship 
for Ag+ (Powers et al. 2010a), which indi­
cates that low AgNP­C concentrations dis­
rupt protein synthesis through a mechanism 
unrelated to freely dissolved Ag+ 
• The restricted effect of AgNP­C to suppress 
the ACh phenotype (Ag+ affects both ACh 
and DA phenotypes) (Powers et al. 2010a). 
A comparison of AgNP­C with the two 
sizes of AgNP­PVP readily illustrates the 
roles of nano  particle coating and size. Particle 
coatings clearly affected biological outcomes: 
One or both PVP­coated particles had greater 
effects than AgNP­C toward cell loss, cell 
size, and promotion of TH activity, yet the 
AgNP­PVPs had no effect on protein synthe­
sis. If the coating simply altered the dissolu­
tion of Ag+, then all the comparative effects 
would have been similar. At the same time, the 
larger­diameter AgNP­PVP had greater effects 
than the smaller nano  particles on most of the 
outcomes. Studies with gold nano  particles 
show that particles ≥ 50 nm are actively taken 
up into cells, whereas smaller particles are 
not (Johnston et al. 2010), thus providing a 
possible explanation for the generally greater 
effects seen here for the larger AgNP­PVP. 
However, this was not the case for the effects 
on differentiation into neuro  transmitter 
pheno  types, where the 10­nm AgNP­PVP had 
promotional effects on DA greater than those 
obtained with the 50­nm nano  particle. Thus, 
AgNPs not only elicit effects distinct from 
those of Ag+, but also display important dif­
ferences that are dictated by particle size and 
coating and specific to each biological process. 
This finding strongly indicates that AgNPs act 
biologically as nano  particles and not just as a 
source of Ag+.
Although we present strong evidence that 
AgNPs work through a combination of Ag+ 
release and mechanisms that reflect actions of 
the AgNPs themselves, more work is clearly 
needed to understand the mechanisms under­
lying nano  particle effects and the inter  actions 
of nano  particles with extra  cellular and intra­
cellular components. With regard to the for­
mer, our data show that immediate, anti  mitotic 
effects of AgNPs are not sensitive to the pres­
ence of serum proteins, but it is certainly likely 
that inter  actions could occur with the more 
prolonged exposures that would occur in vivo 
or as particles interact with proteins on the cell 
Figure 4. Effects of particle size, coating, and composition in undifferentiated PC12 cells after a 24-hr expo-
sure shown by (A) DNA synthesis, (B) protein synthesis, and (C) DNA content. Data represent mean ± SE of 
the percent change from control, based on the number of determinations shown in parentheses. ANOVA for 
each panel indicated a main treatment effect [p < 0.003 or better; (A) F5,67 = 7, (B) F7,50 = 9.2, (C) F9,90 = 5.4]. 
The PVP control group contained the same volume of a 10% PVP stock solution as that of the AgNP-PVP. 
*Significantly different from the corresponding control (p < 0.05 or better) by Fisher’s protected least significant difference test. 
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surface. Indeed, addition of serum mitigates 
the loss of viability during a 24­hr exposure 
to AgNPs in mouse keratino  cytes (Murdock 
et al. 2008). Secondly, the diminished effects 
of AgNP­C versus Ag+ toward oxidative stress 
in undifferentiated cells and toward viability 
in either differentiation state, as well as non­
monotonic effects for these and other variables, 
may reflect protective actions of the citrate 
coating. Soluble citrate could supplement cellu­
lar metabolic and biosynthesis demands (Bauer 
et al. 2005), thereby ameliorating effects of 
AgNP exposure. This could also explain why 
the 50­nm AgNP­PVP, despite its larger size, 
had generally greater effects than AgNP­C at 
the same nominal Ag concentration.
Given the rapid growth in AgNP use 
(Wijnhoven et al. 2009), detailed studies of 
the biological effects on neuro  develop  ment 
are critically important. In vitro models, such 
as that used here, can guide future in vivo 
studies to focus on critical stages of neuronal 
vulnerability, such as neuro  transmitter tar­
gets and under  lying cellu  lar mechanisms. Our 
Figure 5. Effects of particle size, coating, and composition in differentiating PC12 cells shown by (A) oxidative stress (4-day exposure), (B) DNA content (4- and 6-day 
exposure), (C) TH and ChAT (6-day exposure), and (D) TH/ChAT ratio (6-day exposure). Data represent mean ± SE of the percent change from control based on the 
number of determinations shown in parentheses. ANOVA for each panel indicated a main treatment effect [p < 0.02 or better; (A) F6,61 = 15, (B) F5,55 = 15 at 4 days and 
F5,55 = 2.8 at 6 days, (C) F4,48 = 3.8 for TH and F4,52 = 14 for ChAT, (D) F4,35 = 15]. 
*Significantly different from the corresponding control (p < 0.05 or better) by Fisher’s protected least significant difference test. 
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findings point to the likelihood that AgNPs 
are develop  mental neuro  toxicants that will 
display a wide window of vulnerable stages, 
ranging from events in early develop  ment 
(mitosis, cell survival) through later stages 
of neuro  differentiation. The non  monotonic 
dose–response relationships seen with the 
nano  particles, along with the dependence on 
coating and size, point to multiple mecha­
nisms of action rather than a single mecha­
nism. Accordingly, the effects of in vivo 
exposures may differ substantially at different 
develop  mental stages and at different ends of 
the dose–response continuum. One uniform 
finding, however, was that the AgNPs, like 
Ag+, divert the end phenotype away from ACh 
and toward DA, albeit by different contribu­
tory mechanisms for each individual agent. If 
this occurs in vivo, we would expect to find 
substantial miswiring of ACh and DA circuits. 
Accordingly, we would then predict that the 
specific neuro  behavioral outcomes of AgNP 
exposure are likely to include adverse effects on 
cognitive, reward, and motor performance. We 
are currently examining outcomes of AgNP 
exposure in developing zebrafish to determine 
if, as predicted by these in vitro studies, AgNPs 
are develop  mental neuro  toxicants in vivo.
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